Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991072488> ?p ?o ?g. }
- W1991072488 endingPage "9456" @default.
- W1991072488 startingPage "9441" @default.
- W1991072488 abstract "Compound 15 (SAR107375), a novel potent dual thrombin and factor Xa inhibitor resulted from a rational optimization process. Starting from compound 14, with low factor Xa and modest anti-thrombin inhibitory activities (IC50’s of 3.5 and 0.39 μM, respectively), both activities were considerably improved, notably through the incorporation of a neutral chlorothiophene P1 fragment and tuning of P2 and P3–P4 fragments. Final optimization of metabolic stability with microsomes led to the identification of 15, which displays strong activity in vitro vs factor Xa and thrombin (with Ki’s of 1 and 8 nM, respectively). In addition 15 presents good selectivity versus related serine proteases (roughly 300-fold), including trypsin (1000-fold), and is very active (0.39 μM) in the thrombin generation time (TGT) coagulation assay in human platelet rich plasma (PRP). Potent in vivo activity in a rat model of venous thrombosis following iv and, more importantly, po administration was also observed (ED50 of 0.07 and 2.8 mg/kg, respectively). Bleeding liability was reduced in the rat wire coil model, more relevant to arterial thrombosis, with 15 (blood loss increase of 2-fold relative to the ED80 value) compared to rivaroxaban 2 and dabigatran etexilate 1a." @default.
- W1991072488 created "2016-06-24" @default.
- W1991072488 creator A5020092970 @default.
- W1991072488 creator A5022293834 @default.
- W1991072488 creator A5026199225 @default.
- W1991072488 creator A5029229259 @default.
- W1991072488 creator A5029974770 @default.
- W1991072488 creator A5032122887 @default.
- W1991072488 creator A5032626442 @default.
- W1991072488 creator A5034425838 @default.
- W1991072488 creator A5038324394 @default.
- W1991072488 creator A5045819872 @default.
- W1991072488 creator A5048038789 @default.
- W1991072488 creator A5050613516 @default.
- W1991072488 creator A5059000394 @default.
- W1991072488 creator A5070831008 @default.
- W1991072488 creator A5074437646 @default.
- W1991072488 creator A5076911889 @default.
- W1991072488 creator A5078532190 @default.
- W1991072488 creator A5080673609 @default.
- W1991072488 creator A5081818234 @default.
- W1991072488 creator A5087669796 @default.
- W1991072488 creator A5091079663 @default.
- W1991072488 date "2013-12-03" @default.
- W1991072488 modified "2023-10-16" @default.
- W1991072488 title "5-Chlorothiophene-2-carboxylic Acid [(<i>S</i>)-2-[2-Methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a Selective and Potent Orally Active Dual Thrombin and Factor Xa Inhibitor" @default.
- W1991072488 cites W1539796472 @default.
- W1991072488 cites W1628030746 @default.
- W1991072488 cites W1636420862 @default.
- W1991072488 cites W1763028643 @default.
- W1991072488 cites W1878559559 @default.
- W1991072488 cites W1974632012 @default.
- W1991072488 cites W1974709342 @default.
- W1991072488 cites W1978611499 @default.
- W1991072488 cites W1981539699 @default.
- W1991072488 cites W1983279431 @default.
- W1991072488 cites W1987621743 @default.
- W1991072488 cites W1996087638 @default.
- W1991072488 cites W2007045218 @default.
- W1991072488 cites W2013794860 @default.
- W1991072488 cites W2015492400 @default.
- W1991072488 cites W2021283535 @default.
- W1991072488 cites W2025188549 @default.
- W1991072488 cites W2037428681 @default.
- W1991072488 cites W2064675039 @default.
- W1991072488 cites W2072787429 @default.
- W1991072488 cites W2074548352 @default.
- W1991072488 cites W2074631079 @default.
- W1991072488 cites W2078458606 @default.
- W1991072488 cites W2079171445 @default.
- W1991072488 cites W2092802848 @default.
- W1991072488 cites W2093236266 @default.
- W1991072488 cites W2101586347 @default.
- W1991072488 cites W2103157510 @default.
- W1991072488 cites W2103573619 @default.
- W1991072488 cites W2107361996 @default.
- W1991072488 cites W2113446992 @default.
- W1991072488 cites W2120739142 @default.
- W1991072488 cites W2121996197 @default.
- W1991072488 cites W2125336138 @default.
- W1991072488 cites W2130909191 @default.
- W1991072488 cites W2135725837 @default.
- W1991072488 cites W2140902413 @default.
- W1991072488 cites W2142914571 @default.
- W1991072488 cites W2150018158 @default.
- W1991072488 cites W2153438515 @default.
- W1991072488 cites W2161743998 @default.
- W1991072488 cites W2165506983 @default.
- W1991072488 cites W2165639874 @default.
- W1991072488 cites W2170246908 @default.
- W1991072488 cites W2170660770 @default.
- W1991072488 cites W2949690563 @default.
- W1991072488 cites W4233751020 @default.
- W1991072488 cites W9697762 @default.
- W1991072488 doi "https://doi.org/10.1021/jm4005835" @default.
- W1991072488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24175584" @default.
- W1991072488 hasPublicationYear "2013" @default.
- W1991072488 type Work @default.
- W1991072488 sameAs 1991072488 @default.
- W1991072488 citedByCount "20" @default.
- W1991072488 countsByYear W19910724882014 @default.
- W1991072488 countsByYear W19910724882015 @default.
- W1991072488 countsByYear W19910724882016 @default.
- W1991072488 countsByYear W19910724882017 @default.
- W1991072488 countsByYear W19910724882018 @default.
- W1991072488 countsByYear W19910724882019 @default.
- W1991072488 countsByYear W19910724882020 @default.
- W1991072488 countsByYear W19910724882022 @default.
- W1991072488 countsByYear W19910724882023 @default.
- W1991072488 crossrefType "journal-article" @default.
- W1991072488 hasAuthorship W1991072488A5020092970 @default.
- W1991072488 hasAuthorship W1991072488A5022293834 @default.
- W1991072488 hasAuthorship W1991072488A5026199225 @default.
- W1991072488 hasAuthorship W1991072488A5029229259 @default.
- W1991072488 hasAuthorship W1991072488A5029974770 @default.
- W1991072488 hasAuthorship W1991072488A5032122887 @default.
- W1991072488 hasAuthorship W1991072488A5032626442 @default.
- W1991072488 hasAuthorship W1991072488A5034425838 @default.